Organ Donation and Utilization in the United States, 1999–2008

Despite the Organ Donation Breakthrough Collaborative's work to engage the transplant community and the suggested positive impact from these efforts, availability of transplanted organs over the past 5 years has declined. Living kidney, liver and lung donations declined from 2004 to 2008. Living liver donors in 2008 dropped to less than 50% of the peak (524) in 2001. There were more living donors that were older and who were unrelated to the recipient. Percentages of living donors from racial minorities remained unchanged over the past 5 years, but percentages of Hispanic/Latino and Asian donors increased, and African American donors decreased. The OPTN/UNOS Living Donor Transplant Committee restructured to enfranchise organ donors and recipients, and to seek their perspectives on living donor transplantation. In 2008, for the first time in OPTN history, deceased donor organs decreased compared to the prior year. Except for lung donors, deceased organ donation fell from 2007 to 2008. Donation after cardiac death (DCD) has accounted for a nearly 10‐fold increase in kidney donors from 1999 to 2008. Use of livers from DCD donors declined in 2008 to 2005 levels. Understanding health risks associated with the transplantation of organs from ‘high‐risk’ donors has received increased scrutiny.

[1]  F. Delmonico,et al.  Aggressive pharmacologic donor management results in more transplanted organs1 , 2003, Transplantation.

[2]  L. Ratner,et al.  Utilization, Outcomes, and Retransplantation of Liver Allografts From Donation After Cardiac Death: Implications for Further Expansion of the Deceased-Donor Pool , 2008, Annals of surgery.

[3]  D. Segev,et al.  Histidine‐Tryptophan‐Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Pancreas Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  B. Reichart,et al.  Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. , 1987, Transplantation.

[5]  S. Keshavjee,et al.  Normothermic Ex Vivo Perfusion Prevents Lung Injury Compared to Extended Cold Preservation for Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  P. de Vos,et al.  Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors. , 1999, Transplantation.

[7]  R. Ploeg,et al.  Machine perfusion or cold storage in deceased-donor kidney transplantation. , 2009, The New England journal of medicine.

[8]  D. Segev,et al.  Histidine‐Tryptophan‐Ketoglutarate (HTK) Is Associated with Reduced Graft Survival of Deceased Donor Kidney Transplants , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  J. Bragg-Gresham,et al.  Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  H. Bouma,et al.  Signal Transduction Pathways Involved in Brain Death‐Induced Renal Injury , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  G. Rakhorst,et al.  Early Events in Kidney Donation: Progression of Endothelial Activation, Oxidative Stress and Tubular Injury After Brain Death , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.